Novel Drug Design for Treatment of COVID-19: A Systematic Review of Preclinical Studies
Background. Since the beginning of the novel coronavirus (SARS-CoV-2) disease outbreak, there has been an increasing interest in discovering potential therapeutic agents for this disease. In this regard, we conducted a systematic review through an overview of drug development (in silico, in vitro, a...
Saved in:
| Main Authors: | Sarah Mousavi, Shima Zare, Mahmoud Mirzaei, Awat Feizi |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2022-01-01
|
| Series: | Canadian Journal of Infectious Diseases and Medical Microbiology |
| Online Access: | http://dx.doi.org/10.1155/2022/2044282 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Efficacy of autologous platelet concentrates for root coverage of Miller’s Class I and II gingival recession defects: A systematic review and meta-analysis
by: Jaber Yaghini, et al.
Published: (2024-11-01) -
Preclinical Evaluation of a New Anti-COVID-19 Intravenous Immunoglobulin
by: A. M. Nikolaeva, et al.
Published: (2023-02-01) -
Potentially inappropriate medication use and comorbidity in association with quality of life in community-dwelling older people: a cross-sectional study in Iran
by: Maryam Shirdozham, et al.
Published: (2025-05-01) -
Cardiotoxic Drugs Used in the Treatment of COVID-19
by: A. S. Zmitrukevich, et al.
Published: (2024-01-01) -
Animal models in preclinical metastatic breast cancer immunotherapy research: A systematic review and meta-analysis of efficacy outcomes.
by: Yalda Mirzaei, et al.
Published: (2025-01-01)